Category: Editorial

Accelerating the construction of artificial intelligence diagnostic platform based on ophthalmic imaging database

Authors: Lin Haotian,  Wu Xiaohang DOI: 10.3760/cma.j.issn.2095-0160.2018.08.001 Published 2018-08-10 Cite as Chin J Exp Ophthalmol, 2018,36(8): 577-580. Abstract                              [Download PDF] [Read Full Text] With the global trend of aging populations, the prevalence of blindness is expected to increase.However, due to deficiencies and imbalances, […]

Attaching importance to diagnosis and treatment of allergic conjunctivitis

Authors: Wu Kaili,  Li Kunke DOI: 10.3760/cma.j.issn.2095-0160.2018.09.002 Published 2018-09-10 Cite as Chin J Exp Ophthalmol, 2018,36(9): 661-665. Abstract                              [Download PDF] [Read Full Text] Allergic conjunctivitis is one of the most common eye diseases, and its incidence is ever increasing every year.The disease has unbearable ocular symptoms and […]

Pay attention to the drug selection for allergic keratoconjunctivitis

Authors: Hong Jing DOI: 10.3760/cma.j.issn.2095-0160.2018.09.001 Published 2018-09-10 Cite as Chin J Exp Ophthalmol, 2018,36(9): 657-660. Abstract                                [Download PDF] [Read Full Text] Allergic keratoconjunctivitis is a common allergic disease, but some patients, especially children, cannot be diagnosed and treated timely and correctly.Allergic […]

Emphasizing on the importance of RB1 genetic testing in diagnosis/treatment and genetic counseling of retinoblastoma

Authors: Chen Danian,  Fan Yimeng DOI: 10.3760/cma.j.issn.2095-0160.2018.10.002 Published 2018-10-10 Cite as Chin J Exp Ophthalmol, 2018,36(10): 742-747. Abstract                              [Download PDF] [Read Full Text] Retinoblastoma (RB) is the prototype of hereditary neoplasms in humans.It is the most common intraocular malignancy in children, which is mainly caused by RB1 […]

Diagnostic thinking of intraocular neoplasm

Authors: Wei Wenbin,  Zhou Nan DOI: 10.3760/cma.j.issn.2095-0160.2018.10.001 Published 2018-10-10 Cite as Chin J Exp Ophthalmol, 2018,36(10): 737-741. Abstract                              [Download PDF] [Read Full Text] The intraocular tumor has a serious impact on patient’s vision and even life.Early and correct diagnosis can guide the treatment, most patients can retain […]

Focus on the clinical application of limbal stem cells

Authors: Liu Zuguo,  Wang Guoliang,  Li Cheng DOI: 10.3760/cma.j.issn.2095-0160.2018.11.002 Published 2018-11-10 Cite as Chin J Exp Ophthalmol, 2018,36(11): 822-825. Abstract                              [Download PDF] [Read Full Text] Limbal stem cells (LSCs) transplantation is an effective surgical treatment to address limbal stem cells deficiency (LSCD) resulting from Stevens Johnson’s syndrome or […]

Research progress and problems of endogenous neural stem cell properties of retinal Müller cells

Authors: Yin Zhengqin DOI: 10.3760/cma.j.issn.2095-0160.2018.11.001 Published 2018-11-10 Cite as Chin J Exp Ophthalmol, 2018,36(11): 817-821. Abstract                               [Download PDF] [Read Full Text] Retinal degeneration is an incurable and irreversible blinding disease caused by the retinal neural cell death.An effective and safe strategy to substitute these injured cells […]

Pay more attention to drug-induced ocular toxicity

Authors:  Zhang Junjie DOI: 10.3760/cma.j.issn.2095-0160.2018.12.001 Published 2018-12-10 Cite as Chin J Exp Ophthalmol, 2018,36(12): 897-901. Abstract                              [Download PDF] [Read Full Text] Medication safety is one of the primary considerations in drug therapy.With the increase of drug categories and the diversification of drug delivery routes, more and […]

Problems and challenges of anti-vascular endothelial growth factor therapy for ocular neovescularization diseases

Authors: Chen Youxin,  Tang Jia DOI: 10.3760/cma.j.issn.2095-0160.2019.01.001 Published 2019-01-10 Cite as Chin J Exp Ophthalmol, 2019,37(1): 1-4. Abstract                              [Download PDF] [Read Full Text] Anti-vascular endothelial growth factor (VEGF) therapy is a major strategy for treating ocular neovascular diseases nowadays.It has revolutionarily improved the […]

The evolutional and developing mindset in management of ocular trauma in recent ten years

Author: Ma Zhizhong  DOI: 10.3760/cma.j.issn.2095-0160.2019.02.001 Published 2019-02-10 Cite as Chin J Exp Ophthalmol, 2019,37(2): 81-82. Abstract                              [Download PDF] [Read Full Text] The main developments and progresses of the mindset for the management of ocular trauma in China were summarized into the following 6 aspects: the emphasis […]